Arrowhead Pharmaceuticals Inc.

In News

Arrowhead Pharmaceuticals Presents New Long-Term Efficacy and Safety Data for Plozasiran Across a Spectrum of Hypertriglyceridemia at the American College of Cardiology’s 75th Annual Scientific Session and Expo - Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. - Mar 29, 2026

Arrowhead Pharmaceuticals, Inc. (ARWR) Jumps 7.3% to $61.87 - AlphaStreet

AlphaStreet - Mar 31, 2026

Q4 2025 Arrowhead Pharmaceuticals Inc Earnings Call Transcript - gurufocus.com

gurufocus.com - Mar 30, 2026

Arrowhead Pharmaceuticals to Webcast Fiscal 2026 First Quarter Results - Yahoo Finance

Yahoo Finance - Jan 20, 2026

Arrowhead Pharmaceuticals (ARWR) price target increased by 17.24% to 59.24 - MSN

MSN - Mar 29, 2026

Arrowhead Pharmaceuticals Announces FDA Approval of REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS) - Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. - Nov 18, 2025

Arrowhead Pharmaceuticals Inc at TD Cowen Healthcare Conference Transcript - gurufocus.com

gurufocus.com - Mar 30, 2026

Morgan Stanley Notes 2026 Sales From Arrowhead Pharmaceuticals, Inc. (ARWR)’s Familial Chylomicronemia Syndrome Likely Limited - Yahoo Finance

Yahoo Finance - Feb 17, 2026

Arrowhead Pharmaceuticals Receives FDA Breakthrough Therapy Designation for Plozasiran in Severe Hypertriglyceridemia - Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. - Dec 02, 2025

Arrowhead Pharmaceuticals to Participate in Upcoming December 2025 Conferences - Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. - Dec 01, 2025

Arrowhead Pharmaceuticals to Participate in Upcoming November 2025 Conferences - Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. - Nov 04, 2025

Arrowhead Pharmaceuticals to Participate in Upcoming September 2025 Conferences - Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. - Aug 27, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment